Lumira Ventures
VC
INVESTOR TYPE
Active
STATUS
8
PROFESSIONALS
123
INVESTMENTS
28
PORTFOLIO
58
EXITS
Description
Lumira Ventures is a leading health and life sciences venture capital firm that invests in and helps build transformative bio-pharmaceutical and medical device companies located in North America. The firm is a North American healthcare and life sciences venture capital firm, with offices in Toronto, Montreal, Vancouver and Boston, it collaborates with and invests in entrepreneurial management teams to build best-in-class, innovation-centric biotherapeutic and medical device companies.
Website
Formerly Known As
Lumira Capital
Investor Status
Actively Seeking New Investments
Trade Association
Canadian Venture Capital and Private Equity (CVCPE)
Year Founded
1989
Primary Investor Type
Venture Capital
Primary Office
- 141 Adelaide Street
- Suite 770
- Toronto, Ontario M5H 3L5
- Canada
+1 (416) 000-0000
Lumira Ventures Investments (123)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Notch Therapeutics | 05-Nov-2019 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| 0000000000 | 03-Oct-2019 | 0000 00000 | 00.000 | Biotechnology | Startup | |
| 0000000000 | 01-Oct-2019 | 00000 00000 | 0000 | Monitoring Equipment | Generating Revenue | 00000 00000 |
| 0000000 0000000000 | 24-Apr-2019 | 00000 00000 | 0000 | Pharmaceuticals | Generating Revenue/Not Profitable | 00000 00000 |
| 00000 00000000000 | 16-Apr-2019 | 00000 00000 | 000.00 | Monitoring Equipment | Generating Revenue | 00000 00000 |
| 00000000000 | 08-Apr-2019 | 00000 00000 | 0000 | Surgical Devices | Pre-Clinical Trials | 00000 00000 |
| 00000000 | 05-Feb-2019 | 00000 00000 | 00.00 | Surgical Devices | Generating Revenue | 00000 00000 |
| 000000 | 18-Jan-2019 | 00000 00000 | Biotechnology | Generating Revenue | 00000 00000 | |
| Antios Therapeutics | 27-Nov-2018 | Early Stage VC | 0000 | Drug Discovery | Startup | 00000000 00000000 00.0 |
| Antiva Biosciences | 10-Jul-2018 | Later Stage VC | 0000 | Biotechnology | Clinical Trials - Phase 1 | 00000000 00000000 00.0 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Lumira Ventures’s full profile, request a free trial.
Lumira Ventures Exits (58)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Satsuma Pharmaceuticals | 13-Sep-2019 | IPO | 000.00 | Completed |
|
| 000000 0000000 | 19-Jun-2019 | 0000000000: 000000 | Completed |
|
|
| 000000 00000000 | 30-Apr-2018 | 000000000000000000 | 00000 | Completed |
|
| 00 000000000000 | 31-Mar-2018 | 000000000 00000000 | Completed |
|
|
| 0000000 0000000000 | 01-Sep-2017 | 000 00 00000000 | Completed |
|
|
| 00000000 000000000 | 01-Jul-2017 | 000 00 00000000 | Completed |
|
|
| 00 000000000000 | 17-May-2017 | 000 | 00000 | Completed |
|
| 000000000 | 28-Apr-2017 | 000 | 0000 | Completed |
|
| Aurinia Pharmaceuticals | 17-Mar-2017 | Public Investment 2nd Offering | 00000 | Completed |
|
| Argos Therapeutics | 23-Mar-2016 | Secondary Transaction - Open Market | Completed |
|
Lumira Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore Lumira Ventures‘s full profile, request access.
Request full access to PitchBookLumira Ventures Team (31)
15 Former Team Members
You’re viewing 5 of 31 team members. Get the full list »Lumira Ventures Co-Investors (121)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Fonds de solidarité FTQ | 5 | 0 | 0 |
| Aperture Venture Partners | 0 | 0 | |
| BDC Capital | 0 | 0 | 0 |
| Johnson & Johnson Innovation - JJDC | 0 | 0 | |
| Domain Associates | 0 | 0 |